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characteristics. ConClusions: Based on this analysis, substantial proportions of 
patients in Class II and III were not hospitalized, possibly reflecting a trend toward 
treatment of moderate ABSSSI patients in the ambulatory setting. Switching appro-
priate patients from inpatient to OPAT setting could potentially save the health 
system approximately $6,000-7,000/patient.
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OUTCOMES AND EXPENDITURES OF CLOSTRIDIUM DIFFICILE INFECTION IN 
PEDIATRIC SOLID ORGAN TRANSPLANT RECIPIENTS
Ling Y.L., Rascati K.L.
The University of Texas at Austin, College of Pharmacy, Austin, TX, USA
objeCtives: To assess outcomes of clostridium difficile infection (CDI) and the 
association of expenditures and CDI in pediatric solid organ transplant (SOT) recipi-
ents. Methods: Data from the 2000, 2003, 2006, and 2009 Kids’ Inpatient Database 
(KID) files were used to identify events with SOT- related ICD-9-CM diagnosis codes. 
The data were evaluated using logistic regressions and log-linked gamma regres-
sions. Results: The total number of pediatric SOT hospital events was 48,286. 
The overall prevalence of CDI for pediatric SOT hospitalizations was 1.76%. For 
SOT hospitalizations with CDI, inpatient mortality was 1.63%; the prevalence of 
transplant failure or rejection events was 27.71%; the prevalence of a colectomy 
was 4.86%. The median LOS was seven days; the median charge for each hospitali-
zation was $48,409; and the median cost for each hospitalization was $17,412. The 
results showed that CDI was not significantly associated with inpatient mortality 
or transplant failure/ rejection in pediatric SOT hospitalizations, but the power 
to detect differences was low. SOT patients with CDI were 2.6 times more likely 
to have a colectomy than SOT patient without CDI (OR= 2.62, 95% CI= [1.63, 4.22], 
p< 0.001). The mean LOS for a SOT admission with CDI was approximately 2 times 
the mean LOS for a SOT admission without CDI (coefficient= 1.93, 95% CI= [1.68, 
2.21], p< 0.001). The mean charges and the mean costs for a SOT admission with 
CDI was approximately 2 times that for a SOT admission without CDI (charges: 
coefficient= 2.01, 95% CI= [1.63, 2.46], p< 0.001; costs: coefficient= 1.96, 95% CI= [1.50, 
2.58], p< 0.001). ConClusions: CDI diagnoses were not significantly associated 
with higher inpatient mortality or transplant failure/ rejection for pediatric SOT 
hospitalizations. But CDI was significantly associated with a higher prevalence of 
a colectomy, longer hospital LOS, higher charges, and higher costs.
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METhODOLOGICAL ISSUES ASSOCIATED WITh ThE USE OF SOCIAL MEDIA IN 
OUTCOMES RESEARCh: CASE STUDy OF ADULT VACCINATION
Yang H.K.1, Abogunrin S.2, Cox A.2, Khankhel Z.2, Martin A.2, Merinopoulou E.2
1Merck & Co., Inc, West Point, PA, USA, 2Evidera, London, UK
objeCtives: Social media (SM) is increasingly being used as a data resource in 
published scientific literature to study disease burden and perceptions of patients 
and caregivers. However, the feasibility, ethics and legality of using SM in outcomes 
research remain unclear. We aimed to explore these issues in the context of adult 
vaccination. Methods: We searched the internet using different search engines 
and browsers to identify SM sites with content relevant to adult vaccination. We 
developed a decision-matrix based on weighted characteristics to determine which 
sites are most useful for in-depth data analysis. Thirty-five SM sites were scored for 
popularity, amount and type of content relevant to vaccination, data use restric-
tions, and feasibility of accessing the data. Results: SM sites with relevant content 
included general sites such as Facebook, Twitter, and YouTube; and health-specific 
sites such as HealthUnlocked, PatientsLikeMe, and SmartPatients. Although sev-
enteen sites facilitated access to their public-facing content via interfaces such as 
application programming interfaces (APIs), nine sites had limitations to the use of 
public content for non-personal reasons. Two sites did not support the download 
and storing of site content for in-depth analysis and audit, while data from most 
sites could only be downloaded manually or by automatic ‘scraping’. All selected 
sites facilitated responses to an initial post, but only a minority had examples 
of multi-user conversations or discussions about vaccination in adults. The sites 
with the most potential for in-depth data analysis were Google+, Twitter, YouTube, 
Yahoo Answers, and Facebook. ConClusions: Contrary to popular opinion, data 
that is available for all to browse and disseminate rapidly and globally is not always 
legally and practically accessible for research. Clarification of the issues around 
the use of SM for health research is needed to establish best practice guidance for 
this rich resource.
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DRUG UTILIzATION REVIEW OF CARbAPENEMS: A SOLUTION TO IRRATIONAL 
USE OF bROAD SPECTRUM ANTIbIOTICS
Singhal R.1, Mandal A.2, Sharma A.2
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objeCtives: Emergence of resistance towards almost all broad spectrum antibiot-
ics is rapidly increasing and one of the main causes is irrational and inappropriate 
prescription of carbapenems. Hence the current study was carried out to assess 
the prescribing pattern of carbapenems in medical intensive care unit of a private 
tertiary care hospital. Methods: A retrospective observational study was car-
ried out in patients prescribed with carbapenems in MICU for a period of 1 year. 
Only patients having stay of more than 24 hours were included in study. Results: 
Out of total 138 patients, 127 patients were included in the study as per protocol. 
Average age of patient was found to be 55.2 ± 1.684 years. Mean Acute Physiology 
and Chronic Health Evaluation (APACHE) – IV Score was 72.63 which show critical 
condition of the admitted patients. Fifty four percent patients were with severe 
sepsis and 32% were in septic shock. In 86 patients carbapenems were prescribed 
at first day of admission in ICU. Most of the prescribed drug was meropenem fol-
lowed by doripenem and imipenem. Mostly prescribed concomitant antimicrobials 
were glycopeptides, antifungals and metronidazole. Prescription and switching of 
antimicrobials was according to culture sensitivity reports in 97% cases. Survival 
outcome was 64%. ConClusions: Prescription of broad spectrum antimicrobials 
objeCtives: US Health Reform is stimulating new models of care, such as pharma-
cist vaccination programs. While pharmacist vaccination holds promise in improv-
ing access to this important preventive modality, evidence on these programs is still 
emerging. The objective of this research was to conduct a systematic review of pub-
lished evidence on pharmacist immunization programs for two common diseases-- 
influenza and pneumococcal disease. Methods: Ten PubMed literature searches 
were performed using the keywords pharmacist, vaccination, program, policy, cost, 
and education. Inclusion criteria: pharmacist administration of immunizations and 
published between 2000 and 2013. Exclusion criteria: student pharmacists used 
as immunizers and research was non-US. Results: 102 articles were identified. 
Of these, 52 met inclusion criteria; 30 (57.7%) were primary research, 22 (42.3%) 
were secondary research. Older adults (≥ age 65) were the most common target 
for pharmacist vaccination programs (21.2%), followed by 9.6% targeting a specific 
ethnicity, 7.7% targeting individuals with chronic conditions, and 5.8% targeting 
individuals at high risk for the disease. Patient-reported barriers to pharmacist vac-
cination included: accessibility to the pharmacist (42.3%), cost/insurance concerns 
(36.5%), lack of health care provider recommendation (19.2%), lack of awareness 
of the illness (15.4%), and fears that the vaccine will cause illness (11.5%). The lit-
erature lacked program cost and outcome data such as knowledge and vaccina-
tion rates. ConClusions: Though intuitively it would seem that pharmacists are 
highly accessible, the literature suggests that access to pharmacists is, instead, a 
barrier to vaccination, perhaps due to time limitations or physical infrastructure not 
conducive to vaccination. Cost or insufficient insurance coverage for pharmacist-
administered vaccines is also a concern. More evidence is needed on the outcomes 
of these programs in terms of improving pharmacist accessibility, vaccination rates 
and knowledge about the disease, as well as economic data to inform decision mak-
ers on their value in relation to traditional models of care.
PIN98
RACIAL DISPARITIES IN INFLUENzA VACCINATION AMONG ELDERLy: A 
MULTILEVEL MODELING APPROACh
Bali V., Mehta P.
University of houston, houston, TX, USA
objeCtives: Immunization is a cost-effective strategy to reduce the impact of influ-
enza among elderly. The purpose of this study was to examine racial disparities in 
influenza vaccination in elderly after controlling for individual and higher level 
factors. Methods: The 2011 Behavioral Risk Factor Surveillance System Selected 
Metropolitan/Metropolitan Area Risk Trends (BRFSS SMART) dataset was used for 
this study. Study population consisted of individuals aged 65 years or above and 
those who responsded as either yes or no about having received seasonal flu shot/
spray during the last one year. Race, age, gender, education level, employment sta-
tus, marital status, health insurance coverage and medical cost were used as level 
1 variables. United States county code and race aggregated at level 2 were used as 
level 2 variables. Two-level logistic regression analysis was used to examine racial 
disparities in influenza vaccination in elderly. Results: The study cohort consisted 
of 66,165 subjects. Of these, 41,427 (62.61%) received influenza vaccination. Mean 
age of the study sample was 75 years (74.64 ± 7.20). Most of the elderly patients 
receiving influenza vaccination were females (64.09%), Whites (87.99%), and insured 
(99.86%). Results from multilevel modeling suggested that individuals’ race (odds 
ratio:1.289, p value < .0001), and other factors like age, gender, education level, 
employment status, marital status, health insurance coverage and medical cost 
were significantly associated with influenza vaccination in elderly. Effect of race 
varied significantly across counties for influenza vaccination in elderly. Additionally, 
county-level race moderated the effect of individual race for influenza vaccination 
in elderly. ConClusions: Racial disparities exist in influenza vaccination among 
elderly even after controlling for individual and higher level factors. Individual level 
factors were better predictors of influenza vaccination in elderly than the level 2 
factors. However, it is always desirable to use multilevel approach when the nature 
of the data is inherently nested.
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SEVERITy AND COSTS OF ACUTE bACTERIAL SkIN AND SkIN STRUCTURE 
INFECTIONS by TREATMENT SETTING: AN APPLICATION OF ThE ERON 
CLASSIFICATION TO A REAL-WORLD DATAbASE
Sulham K.1, LaPensee K.2, Fan W.3, Lodise T.P.4
1The Medicines Company, Waltham, MA, USA, 2The Medicines Company, Parsippany, NJ, USA, 
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Albany, NY, USA
objeCtives: Acute bacterial skin and skin structure infections (ABSSSIs) are the 
second most common indication for antibiotic treatment. Eron et al. developed 
an algorithm for disease severity and appropriate treatment to optimize patient 
care and minimize costs. However, this algorithm has yet to be thoroughly vali-
dated in the real-world. The objectives of this study were to investigate the current 
ABSSSI patient population and compare the direct health care costs associated with 
inpatient versus outpatient parenteral antimicrobial therapy (OPAT) treatment, by 
patient severity level, in the US. Methods: ABSSSI patient characteristics were 
evaluated using the Premier Hospital Database. Standard data elements in hospital 
discharge files, including diagnoses and procedures categorized by International 
Classification of Diseases, Ninth Revision were used to classify patients according 
to the Eron classes I-IV. Data for this study were extracted from January to Dec 
2012. Results: There were 533,263 hospital and emergency room discharges with 
a principal diagnosis of ABSSSI included for analysis. The percentages of patients 
categorized as Eron Class I-IV were 73.47%, 20.15%, 4.75% and 1.63% respectively. 
20.35% of patients were hospitalized; 9.26%, 43.51%, 71.36% and 85.54% in Class I-IV 
respectively. The unadjusted costs associated with inpatient versus OPAT treat-
ment varied substantially by disease severity: mean costs were $5,729 inpatient vs. 
$368 OPAT for Class I, $7,651 vs. $634 for Class II, $10,339 vs. $823 for Class III, and 
$16,559 vs. $1,050 for Class IV. The cost increases for inpatient versus OPAT treat-
ment ranged from $6,303 to $7,351 for Class II and III after adjustment for baseline 
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or previous use of inhaled anticholinergics was not associated with a significant 
increased risk of AACG (active use: adjusted OR 1.32, 95% CI 0.83-2.10; non-active 
use: adjusted OR 1.13, 95% CI 0.72-1.75) compared to non-use, adjusting for use of 
other medications related to AACG. ConClusions: A relationship between the use 
of inhaled anticholinergics and the risk of AACG was not observed in this COPD pop-
ulation. However, the findings are limited due to the small sample size of the events.
PSS3
VALIDATION OF AN ICD-9-bASED CLAIMS ALGORIThM FOR IDENTIFyING 
PATIENTS WITh ChRONIC IDIOPAThIC/ SPONTANEOUS URTICARIA
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objeCtives: Chronic idiopathic/spontaneous urticaria (CIU) is a skin condition 
characterized by the presence of hives and angioedema lasting ≥ 6 weeks with no 
known cause. There is no specific ICD-9 code for CIU. This study aims to validate 
an ICD-9 based algorithm to identify patients with CIU to allow for epidemiologic 
research using administrative claims databases. Methods: Retrospective review 
of medical and billing records in 4 geographically-dispersed US allergy practices. 
Patients were eligible for inclusion if they met the either of these criteria: 1) ≥ 2 out-
patient visits with a diagnosis of idiopathic urticaria (ICD-9 708.1), other specified 
urticaria (708.8), or unspecified urticaria (708.9) ≥ 6 weeks apart, OR 2) ≥ 1 outpatient 
diagnosis of 708.1, 708.8 or 708.9 and 1 diagnosis of angioedema (995.1) ≥ 6 weeks 
apart. A random sample of patients known to have CIU were also included. Chart 
review was performed to collect information on ICD-9 codes, prescription medica-
tions, and clinical urticarial diagnoses abstracted from records of a random sample 
of eligible patients. Sensitivity and positive predictive value (PPV) were calculated. 
The study received central IRB approval. Results: There were 149 patients with a 
mean age of 41.1 years (SD: 20.8), 73.8% were female and 69.1% were white. For 104 
“true positive” patients, the mean (median) duration of CIU was 3.1(2.5) years. The 
claims algorithm had sensitivity of 71.1% and PPV of 90.4%. Using just the first algo-
rithm reduced PPV to 90.3% and sensitivity to 67.8%. Physicians most often identified 
CIU using the codes for idiopathic urticaria, unspecified urticaria and other urticarial 
conditions. ConClusions: PPV of 90.4% suggests patients identified using the 
tested ICD-9 algorithm are highly likely to have CIU. Sensitivity of 71.1% suggests 
that some patients with CIU would not be identified. Changes to the algorithm that 
increase sensitivity without decreasing PPV should be explored in future studies.
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VISUAL FUNCTION AND ANATOMIC RESPONSES TO OCRIPLASMIN
Jackson T.1, Verstraeten T.2, Duchateau L.3, Lescrauwaet B.3
1King’s College hospital, London, UK, 2P95, Leuven, Belgium, 3Xintera Ltd., London, UK
objeCtives: Vitreomacular adhesion (VMA) can lead to pathologic traction and 
macular hole formation. In two phase 3 trials ocriplasmin induced a significant ana-
tomical response, as well as a significant functional response. The purpose of this 
analysis was to assess how the anatomic and visual function responses related to 
each other. Methods: An anatomic response was defined as complete non-surgical 
resolution of vitreomacular adhesion (VMA). Visual functional response was defined 
as either: non-surgical visual acuity improvement of ≥ 2 lines; or clinically mean-
ingful improvement in the visual function questionnaire (VFQ-25) composite score 
(> 3.6 points) or driving subscale (> 19.1 points). We defined complete responders 
as participants who improved both anatomically and functionally. Visual-function-
only responders, or anatomic-only-responders, were participants who improved 
in either category (but not both), and non-responders were participants without 
improvement in either category. We investigated the ocriplasmin effect for each 
of these response categories using generalized logit regression models with the 
non-responder group as baseline category. Results: The proportion of complete 
responders in the ocriplasmin group was 18.3%, versus 5.2% in the placebo group 
(p= 0.003). The proportion of visual-function-only responders was 36.8% and 29.0% 
(p= 0.0007); and the proportion of anatomic-only-responders was 10.2% and 5.2%, 
for ocriplasmin and placebo groups respectively (p< 0.0001). Ocriplasmin treatment 
produced a visual function response, either alone or in combination with an ana-
tomic response, in 55.1% of patients, compared to 34.2% of patients receiving pla-
cebo. ConClusions: The reason why visual function was larger than the anatomic 
response in the ocriplasmin treated group is not known, but the possibility of partial 
release of VMA positively affecting visual function warrants further investigation.
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PREVALENCE, INCIDENCE AND ChARACTERISTICS OF PATIENTS WITh 
ChOROIDAL NEOVASCULARIzATION SECONDARy TO PAThOLOGIC MyOPIA IN A 
REPRESENTATIVE CANADIAN COhORT
Zaour N.1, Luciani L.2, Petrella R.J.3
1Novartis Pharmaceuticals Canada Inc., Dorval, QC, Canada, 2Université de Montréal, Montreal, 
QC, Canada, 3Lawson health Research Institute, London, ON, Canada
objeCtives: Choroidal neovascularization (CNV) is the most common vision-
threatening complication associated with pathologic myopia (PM), or myopic CNV 
(mCNV). There is a lack of information on the epidemiology related to mCNV in 
the world and more so in Canada. This study aimed to determine the epidemi-
ology and the demographic and treatment characteristics of Canadian mCNV 
patients. Methods: Records from a longitudinal population-based database of 
more than 320,000 patients, collected from 75 physicians in Southwestern Ontario, 
Canada were analyzed between January 1, 2006 and December 31, 2011. Patient 
records were limited to subjects aged 18 years and older, and patients with at least 
one year of follow up. The clinical and demographics characteristics, medications, 
and resource use were reported in this study. A nested case-control study based on 
the final diagnosis of CNV secondary to PM was constructed within a PM cohort. In 
according to culture sensitivity reports is one of the rational utilization practices 
and one of the most important steps for combating multi drug resistance issue.
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PERSISTENT OTITIS MEDIA AMONG TEXAS MEDICAID ChILDREN – PREVALENCE 
AND hEALTh CARE UTILIzATION AND COSTS
Richards K.M., Lawson K.A., Nwokeji E.D., Ma X.
The University of Texas at Austin, Austin, TX, USA
objeCtives: To evaluate utilization patterns and health care costs among chil-
dren in Texas Medicaid diagnosed with otitis media (OM), and analyze the rela-
tionship between index antibiotic medication and prevalence of persistent OM 
(POM). Methods: A retrospective analysis of Texas Medicaid outpatient medical 
and prescription claims from July 2007 to August 2011 for beneficiaries (0-18 years) 
with an OM diagnosis (ICD-9: 381-382) and an associated antibiotic medication was 
conducted. POM was defined as having a subsequent OM diagnosis within 45 days 
after starting the index antibiotic medication. OM-related costs were compared 
across medications and logistic regression was used to evaluate POM likelihood by 
medication with demographics and costs as covariates. Utilization patterns will 
be described graphically using data visualization. Results: The study sample 
included 307,107 patients with a mean age of 3.0 years (SD= 3.8), a majority being 
male (51.9%), Hispanic (63.8%), and from an urban region (84.3%). The overall preva-
lence of POM was 19.3%. Total mean OM episode-related costs were 2.0 times higher 
for POM patients compared to non-POM patients, and the total OM-related cost to 
Medicaid was approximately $58 million. Four index antibiotics (noting their asso-
ciated POM prevalence) were studied: amoxicillin (19.0%), amoxicillin-clavulanate 
(21.2%), azithromycin (15.1%), and cefdinir (21.4%). The second least expensive index 
medication (azithromycin) had the lowest POM prevalence (15.1%) and the second 
lowest mean total OM-related costs ($194; SD= $313). Mean outpatient costs were 
similar between patients taking amoxicillin and cefdinir (the least and most expen-
sive medications, respectively), while amoxicillin-clavulanate and azithromycin 
patients’ outpatient costs were significantly higher (p< 0.01). Age, race, Texas region, 
index medication, and index medication cost category (low vs. high) were significant 
predictors (p< 0.01) of a POM episode. ConClusions: The data suggest different 
POM prevalence among index antibiotic medications, with POM patients accounting 
for a disproportionally higher portion of OM-related health care costs.
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ACETAMINOPhEN IS ASSOCIATED WITh SERIOUS SkIN REACTIONS
Ali A.K.
Eli Lilly and Company, Indianapolis, IN, USA
objeCtives: To detect and clarify signals of serious skin reactions associated with 
acetaminophen, including Stevens-Johnson syndrome (SJS), toxic epidermal necrol-
ysis (TEN), and acute generalized exanthematous pustulosis (AGEP). Methods: 
Cases reported to FDA adverse event reporting system between 1997 and 2012 
were retrieved. The MedDRA Preferred Terms were used to define serious skin 
reactions. Acetaminophen products were identified by generic names. Empirical 
Bayes Geometric Mean (EBGM) with 95% confidence interval (EB05-EB95) was cal-
culated as disproportionality measure. Safety signals with EB05≥ 2 was considered 
a significant disproportional increase in event reporting of at least twice times 
higher than expected. Signals were reported for single-ingredient acetaminophen 
products, acetaminophen-containing combination products. Results: A total of 
1,295 reports of serious skin reactions were submitted for acetaminophen (592) 
and acetaminophen-containing products (703). Strongest serious skin event signals 
were detected for acetaminophen (EBGM= 5.03, EB05-EB95= 4.68-5.40) followed by 
acetaminophen-containing products (EBGM= 2.93, EB05-EB95= 2.75-3.13). Signals of 
SJS (n= 262, EB05= 3.29), TEN (n= 266, EB05= 7.15), and AGEP (n= 64, EB05= 5.55) were 
detected for acetaminophen. Except for SJS (n= 316, EB05= 1.94), signals of TEN 
(n= 304, EB05= 4.00) and AGEP (n= 83, EB05= 3.68) were detected for acetaminophen-
containing products. ConClusions: Treatment with acetaminophen might be 
associated with risks of serious skin reactions, including SJS, TEN, and AGEP. Patients 
should discontinue acetaminophen and seek medical attention when signs and 
symptoms of skin reactions occur. Signal evaluation measures are required to fur-
ther characterize the dermal risk profile of acetaminophen.
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RISk OF ACUTE ANGLE-CLOSURE GLAUCOMA ASSOCIATED WITh INhALED 
ANTIChOLINERGIC AGENTS IN A COPD POPULATION
Lee W.J., Lee T.A.
University of Illinois at Chicago, Chicago, IL, USA
objeCtives: Several cases of acute angle-closure glaucoma (AACG) have been 
reported due to use of inhaled anticholinergics. This study aims to evaluate the 
association between use of inhaled anticholinergics and risk of AACG among a 
population with chronic obstructive pulmonary disease (COPD). Methods: A 
nested case-control study was conducted among a cohort of subjects with new 
use of COPD medications in the IMS Lifelink Health Databases from Jan 1st 2005 to 
Dec 31st2011. Cases were identified as those with a new diagnosis of AACG (ICD-9 
365.22). For each case, up to 4 controls were randomly selected and matched on age, 
gender, geographic area, prevalent glaucoma, and cohort entry year and quarter 
using incident-density sampling. Conditional logistic regression was used to com-
pute the odds ratio (OR) and 95% confidence interval (CI) for active and previous 
use of inhaled anticholinergics. Active use was defined as concurrent use of inhaled 
anticholinergics on the event date. Previous use was defined as patients receiving 
prescription of inhaled anticholinergics one year prior to the event date. Results: 
The study cohort was comprised of 231,256 patients with a COPD diagnosis and 
first-use of COPD medications. The average age was 70.2 years old and 45.6% were 
males. A total of 261 cases with AACG were matched to 1,016 controls. Active use 
